COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$478,761
-43.0%
22,372
+7.6%
0.00%
-42.9%
Q1 2023$840,667
+86566.7%
20,788
-0.3%
0.01%
-12.5%
Q4 2022$970
-99.9%
20,850
+17.5%
0.01%
-11.1%
Q3 2022$921,000
+16.0%
17,750
+5.6%
0.01%
+12.5%
Q2 2022$794,000
-29.1%
16,805
+6.8%
0.01%
-27.3%
Q1 2022$1,120,000
+10.1%
15,734
+15.7%
0.01%0.0%
Q4 2021$1,017,000
+31.2%
13,598
-0.3%
0.01%
+22.2%
Q3 2021$775,000
+27.7%
13,641
-1.1%
0.01%
+28.6%
Q2 2021$607,000
-11.1%
13,793
-0.4%
0.01%
-12.5%
Q1 2021$683,000
+17.2%
13,845
+0.0%
0.01%0.0%
Q4 2020$583,000
-8.2%
13,843
-0.1%
0.01%
-33.3%
Q3 2020$635,000
+54.9%
13,862
+70.0%
0.01%
+50.0%
Q2 2020$410,000
-0.7%
8,156
+1.5%
0.01%
-11.1%
Q1 2020$413,000
+23.3%
8,039
+48.4%
0.01%
+50.0%
Q4 2019$335,000
+3.1%
5,417
+0.2%
0.01%0.0%
Q3 2019$325,000
-29.3%
5,407
-0.9%
0.01%
-25.0%
Q2 2019$460,000
-10.9%
5,457
+1.0%
0.01%
-11.1%
Q1 2019$516,000
+35.1%
5,405
+0.2%
0.01%
+12.5%
Q4 2018$382,000
+19.4%
5,395
+44.0%
0.01%
+60.0%
Q3 2018$320,000
-9.6%
3,747
+22.6%
0.01%0.0%
Q2 2018$354,0003,0570.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders